These studies emphasize the importance of expanding our understanding of the role of COX-2 in altering the tumor phenotype and of non-invasively identifying tumors that have increased COX-2 expression and functionality, to select for COX-2 targeting. The gene discussed is PTGS2; the disease is neoplasm.